Biomanufacturing
What are the most significant manufacturing hurdles in biopharma and how can they be addressed?
Pharma's Almanac
PAO-06-25-RT-02Jun 30, 2025
Supply Chain
What strategies are ensuring supply chain resilience in a post-COVID world?
Pharma's Almanac
PAO-02-25-RT-02Feb 26, 2025
Sustainability
How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?
Pharma's Almanac
PAO-01-25-RT-02Jan 31, 2025
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03Mar 08, 2024
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02Sep 15, 2023
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Pharma's Almanac
PAO-07-23-RT-01Jul 21, 2023
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01Oct 11, 2022
Leadership
Q: What’s the key to being a leader in the industry?
Pharma's Almanac
PAO-03-022-RT-02Mar 11, 2022
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
Pharma's Almanac
PAO-03-022-RT-01Mar 11, 2022
COVID-19
Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin
Sterling Pharma Solutions
PR-M08-20-NI-02Jul 30, 2020